Liang Huang

机构：Tianjin University of Technology, Nanchang University, Army Medical University, National Medical Products Administration, Sichuan University, West China Second University Hospital of Sichuan University, Daping Hospital, Fudan University Shanghai Cancer Center, Nanfang Hospital, Fujian Academy of Agricultural Sciences, Wuhou District People's Hospital, Chengdu, Wuhan Union Hospital, Institute of Hematology & Blood Diseases Hospital, Tongji Hospital, Union Hospital, First Affiliated Hospital of Nanchang University, Huazhong University of Science and Technology, Army Medical College, Xi'an Jiaotong University, University of South China · ORCID：0000-0002-8370-3232

发表论文 485 篇 · 总被引 8894 次 · h-index 47

代表论文

Prediction Models and Risk Factors for Steroid Resistance in Children with Nephrotic Syndrome: A Systematic Review and Meta-Analysis (2026 · Journal of Clinical Medicine · 被引 1)
Unraveling cellular and molecular mechanisms of relapse in CD19/CD22 dual-targeting chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia (2026 · Leukemia · 被引 1)
Engineered extracellular vesicles displaying bi-specific T-cell engagers for targeted therapy of B-cell malignancies (2026 · Experimental Hematology and Oncology · 被引 1)
Application of an AI-enabled personalized medical education model for improving clinical thinking among cardiovascular surgery trainees (2026 · BMC Medical Education)
Long-term follow-up of third generation anti-CD30 CAR T-cell therapy in relapsed/refractory CD30+ lymphomas: a single-arm, multicentre, phase 1-2 trial (2026 · Clinical Cancer Research)
Long-term follow-up of third generation anti-CD30 CAR T-cell therapy in relapsed/refractory CD30+ lymphomas: a single-arm, multicentre, phase 1-2 trial (2026 · Vivli)